212494 (RSV OA=ADJ-006) - A Phase 3, Randomized, Placebo-Controlled, Observer-Blind, Multi-Country Study to Demonstrate the Efficacy of a Single Dose of GSK's RSVPreF3 OA Investigational Vaccine in Adults Aged 60 Years and Above.

  • Ison, Michael G (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date10/14/21 → 10/14/24

Funding

  • Corixa Corporation (212494(RSV OA=ADJ-006))